爱博医疗拟收购德美医疗不低于51%股权

Group 1 - The core point of the article is that Aibo Medical (688050) has signed a letter of intent to acquire at least 51% of the shares of Demai Medical (Chongqing) Technology Co., Ltd., thereby gaining control of the company [1] - The acquisition will be financed through a combination of acquisition loans and the company's own funds [1] - Demai Medical is recognized as a leading enterprise in sports medicine in China, classified as a national high-tech enterprise and a "specialized, refined, distinctive, and innovative" small giant [1] Group 2 - Demai Medical holds 276 patented technologies and has established a modern production base and research center, demonstrating strong technological research and market competitiveness [1]